Ве молиме користете го овој идентификатор да го цитирате или поврзете овој запис: http://hdl.handle.net/20.500.12188/33444
DC FieldValueLanguage
dc.contributor.authorSpasovski, Goceen_US
dc.contributor.authorTrajcheska, Ladaen_US
dc.contributor.authorRambabova Bushljetic, Irenaen_US
dc.date.accessioned2025-05-08T12:41:29Z-
dc.date.available2025-05-08T12:41:29Z-
dc.date.issued2022-08-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/33444-
dc.description.abstractAlthough early rejection episodes are successfully controlled, the problem of unrecognized production of de novo anti-HLA antibodies and associated chronic rejection still persists.en_US
dc.language.isoenen_US
dc.publisherInforma UK Limiteden_US
dc.relation.ispartofExpert Opinion on Pharmacotherapyen_US
dc.subjectkidney transplantationen_US
dc.subjectcalcineurin inhibitorsen_US
dc.subjectbelatacepten_US
dc.subjecteverolimusen_US
dc.subjectsirolimusen_US
dc.subjecteculizumaben_US
dc.subjectclazakizumaben_US
dc.subjecttocilizumaben_US
dc.titlePharmacotherapeutic options for the prevention of kidney transplant rejection: the evidence to dateen_US
dc.typeArticleen_US
dc.identifier.doi10.1080/14656566.2022.2102418-
dc.identifier.urlhttps://www.tandfonline.com/doi/pdf/10.1080/14656566.2022.2102418-
dc.identifier.volume23-
dc.identifier.issue12-
dc.identifier.fpage1397-
dc.identifier.lpage1412-
item.fulltextNo Fulltext-
item.grantfulltextnone-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Journal Articles
Прикажи едноставен запис

Google ScholarTM

Проверете

Altmetric


Записите во DSpace се заштитени со авторски права, со сите права задржани, освен ако не е поинаку наведено.